Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
27.9%
% of BBP's 65 holdings also in IDNA
37.8%
% of IDNA's 49 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
LIGAND PHARMACEUTICALS-CL B | 1.9% | 2.4% | 1.9% |
|
GILEAD SCIENCES INC | 1.8% | 5.9% | 1.8% |
|
BIOCRYST PHARMACEUTICALS INC | 1.8% | 1.7% | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.7% | 4.2% | 1.7% |
|
INCYTE CORP | 1.6% | 4.9% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to IDNA
|
MIRUM PHARMACEUTICALS, INC. | 2.4% |
|
ALNYLAM PHARMACEUTICALS INC | 2.1% |
|
TRAVERE THERAPEUTICS, INC. | 2.0% |
|
LEXICON PHARMACEUTICALS, INC. | 1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 1.9% |
|
ACADIA PHARMACEUTICALS INC | 1.9% |
|
IONIS PHARMACEUTICALS, INC. | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.8% |
|
TG THERAPEUTICS INC | 1.8% |
|
ADMA BIOLOGICS, INC. | 1.8% |
BBP Underweight Relative to IDNA
|
EXELIXIS INC | -5.2% |
 |
BEIGENE, LTD. | -4.8% |
|
REVOLUTION MEDICINES, INC. | -4.7% |
 |
ROCHE HOLDING LTD | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
GILEAD SCIENCES INC | -4.2% |
 |
SANOFI-AVENTIS | -4.0% |
|
ARCELLX, INC. | -3.9% |
 |
BIONTECH SE SPONSORED ADR | -3.7% |
 |
GSK PLC | -3.4% |